| Gabrielle Worzella, DO | |
|
220 Unity St, Bellingham, WA 98225-4420 | |
| (360) 676-6177 | |
| (360) 671-3574 |
| Full Name | Gabrielle Worzella |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 11 Years |
| Location | 220 Unity St, Bellingham, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083054050 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OP60831181 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| All Brains Belong Vt Inc | 9133526387 | 3 |
News Archive
Cylene Pharmaceuticals, Inc. will report recent developments with its first-in-class, oral CK2 inhibitor CX-4945, at the 6th International Conference on Protein Kinase CK2, to be held on September 7-10 in Cologne, Germany, the company announced today.
A type 2 diabetes drug taken orally and in widespread use for more than a decade has been found to have distinct advantages over nine other, mostly newer medications used to control the chronic disease, according to a study by researchers at Johns Hopkins.
Scientists funded by the Biotechnology and Biological Sciences Research Council have harnessed a new drug discovery tool to identify a new player in the body's insulin secretion process.
Addiction is a brain disease that destroys lives, devastates families and tears at the very fabric of society. Effective prevention and treatment of addiction requires a clear understanding of the complex brain mechanisms that underlie addictive behaviors, and research has provided a fascinating view of how substance abuse hijacks neuronal circuits involved in reward and motivation and causes profound and persistent changes in behavior.
Shire plc, the global specialty biopharmaceutical company, announced the divestiture of Daytrana (methylphenidate transdermal system) to Noven Pharmaceuticals, Inc. Daytrana, which is approved and marketed in the US for the treatment of Attention Deficit Hyperactivity Disorder in children and adolescents, will continue to be available for patients through Noven.
› Verified 5 days ago
| Entity Name | All Brains Belong Vt Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861168718 PECOS PAC ID: 9133526387 Enrollment ID: O20210930001879 |
News Archive
Cylene Pharmaceuticals, Inc. will report recent developments with its first-in-class, oral CK2 inhibitor CX-4945, at the 6th International Conference on Protein Kinase CK2, to be held on September 7-10 in Cologne, Germany, the company announced today.
A type 2 diabetes drug taken orally and in widespread use for more than a decade has been found to have distinct advantages over nine other, mostly newer medications used to control the chronic disease, according to a study by researchers at Johns Hopkins.
Scientists funded by the Biotechnology and Biological Sciences Research Council have harnessed a new drug discovery tool to identify a new player in the body's insulin secretion process.
Addiction is a brain disease that destroys lives, devastates families and tears at the very fabric of society. Effective prevention and treatment of addiction requires a clear understanding of the complex brain mechanisms that underlie addictive behaviors, and research has provided a fascinating view of how substance abuse hijacks neuronal circuits involved in reward and motivation and causes profound and persistent changes in behavior.
Shire plc, the global specialty biopharmaceutical company, announced the divestiture of Daytrana (methylphenidate transdermal system) to Noven Pharmaceuticals, Inc. Daytrana, which is approved and marketed in the US for the treatment of Attention Deficit Hyperactivity Disorder in children and adolescents, will continue to be available for patients through Noven.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gabrielle Worzella, DO 1616 Cornwall Ave Ste 205, Bellingham, WA 98225-4642 Ph: (360) 676-6177 | Gabrielle Worzella, DO 220 Unity St, Bellingham, WA 98225-4420 Ph: (360) 676-6177 |
News Archive
Cylene Pharmaceuticals, Inc. will report recent developments with its first-in-class, oral CK2 inhibitor CX-4945, at the 6th International Conference on Protein Kinase CK2, to be held on September 7-10 in Cologne, Germany, the company announced today.
A type 2 diabetes drug taken orally and in widespread use for more than a decade has been found to have distinct advantages over nine other, mostly newer medications used to control the chronic disease, according to a study by researchers at Johns Hopkins.
Scientists funded by the Biotechnology and Biological Sciences Research Council have harnessed a new drug discovery tool to identify a new player in the body's insulin secretion process.
Addiction is a brain disease that destroys lives, devastates families and tears at the very fabric of society. Effective prevention and treatment of addiction requires a clear understanding of the complex brain mechanisms that underlie addictive behaviors, and research has provided a fascinating view of how substance abuse hijacks neuronal circuits involved in reward and motivation and causes profound and persistent changes in behavior.
Shire plc, the global specialty biopharmaceutical company, announced the divestiture of Daytrana (methylphenidate transdermal system) to Noven Pharmaceuticals, Inc. Daytrana, which is approved and marketed in the US for the treatment of Attention Deficit Hyperactivity Disorder in children and adolescents, will continue to be available for patients through Noven.
› Verified 5 days ago
Dr. Kellie L. Jacobs, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3500 Orchard Pl, Bellingham, WA 98225 Phone: 360-671-3900 Fax: 360-647-0882 | |
Lora C Sherman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4455 Cordata Pkwy, Bellingham, WA 98226 Phone: 360-671-3225 Fax: 360-671-0000 | |
Dr. Jessica Ruth Hanford, M.D., MPH Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3015 Squalicum Parkway, Suite 220, Bellingham, WA 98225 Phone: 360-676-1693 Fax: 360-676-5458 | |
Elijah Kamermans, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2608 Kwina Rd, Bellingham, WA 98226 Phone: 360-312-2000 | |
Dr. Warren Billings Howe, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 516 High St, Wwu Student Health (ms-9132), Bellingham, WA 98225 Phone: 360-650-3400 Fax: 360-650-3883 | |
Dr. Denis G. Foster, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 709 W Orchard Dr, Suite 4, Bellingham, WA 98225 Phone: 360-318-8800 Fax: 360-318-1085 |